CNS Depressants

Links shared publicly online about this topic

FDA Panel Looks at CNS Depressant for Fibromyalgia - QualityPoint Technologies

qualitypointtech.net — “BETHESDA, Md. (MedPage Today) -- A joint FDA advisory committee will meet here Friday to consider whether the narcolepsy drug sodium oxybate (Xyrem) should receive an additional indication to treat fibromyalgia.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on August 19, 2010 at 11:21 pm By:

MedicalFeed MedicalFeed Health News Feed

FDA Panel Looks at CNS Depressant for Fibromyalgia: BETHESDA, Md. (MedPage Today) -- A joint FDA advisory committe... http://bit.ly/9l81Vz

1 year ago...

Medical News: FDA Panel Looks at CNS Depressant for Fibromyalgia - in Rheumatology, Fibromyalgia from MedPage Today

medpagetoday.com — “BETHESDA, Md. -- A joint FDA advisory committee will meet here Friday to consider whether the narcolepsy drug sodium oxybate (Xyrem) should receive an additional indication to treat fibromyalgia.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on August 19, 2010 at 10:58 pm By:

PattyGrace Patricia Grace Eldercare Expert

FDA Panel Looks at CNS Depressant for Fibromyalgia: BETHESDA, Md. (MedPage Today) -- A joint FDA advisory committe... http://bit.ly/cuYj9k

1 year ago...

Neura.net: Perspectives on CNS Disease Management

neura.net — “Neura.net: Perspectives on CNS Disease ManagementView full resource at neura.net

  • View Related
  • Share

Most Recently Shared on December 31, 2009 at 2:51 am By:

NeuraNet Neuranet News Medical Education

Peruse & print out MS patient literature, incl. articles about depression, caregiving, vision problems, & drug dvlpmnt. http://bit.ly/64c9lU

2 years ago...

Landmark Results From Depression Efficacy Study To Be Presented By CNS Response At U.S. Psychiatric And Mental Health Congress

medicalnewstoday.com — “Cns response, inc. (otcbb: cnso) announced that the company will present top-line results from its multi-site clinical trial next week at the u.s. psychiatric and mental health congress. referenView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on October 29, 2009 at 11:58 am By:

mnt_mentalhealt MNT Mental Health Health News

Landmark Results From Depression Efficacy Study To Be Presented By CNS Response At U.S. Psychiatric And Mental .. http://bit.ly/1kyKGs

2 years ago...

Landmark Results From Depression Efficacy Study To Be Presented By CNS Response At U.S. Psychiatric And Mental Health Congress

medicalnewstoday.com — “CNS Response, Inc. (OTCBB: CNSO) announced that the company will present top-line results from its multi-site clinical trial next week at the U.S. Psychiatric and Mental Health Congress. ReferenView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on October 29, 2009 at 11:32 am By:

psychiatry_md psychiatryrounds Support and Psychiatry

Landmark Results From Depression Efficacy Study To Be Presented By CNS Response At U.S. Psychiatric And Mental .. http://bit.ly/11bXd

2 years ago...

Landmark Results From Depression Efficacy Study To Be Presented By CNS Response At U.S. Psychiatric And Mental Health Congress | Psydir News

news.psydir.com — “CNS Response, Inc. (OTCBB: CNSO) announced that the company will present top-line results from its multi-site clinical trial next week at the U.S. Psychiatric and Mental Health Congress.View full resource at news.psydir.com

  • View Related
  • Share

Most Recently Shared on October 30, 2009 at 5:27 am By:

psydir PsyDir News Health News

Landmark Results From Depression Efficacy Study To Be Presented By CNS Response At U.S. Psychiatric And Mental Heal... http://ow.ly/15YgVO

2 years ago...

Chocolate: cause or cure for depression? | NutritionData.com Blog by Monica Reinagel, L.D.N., C.N.S.

blog.nutritiondata.com — “Curious findings on the relationship between chocolate and depression in this weeks Archives of Internal Medicine. Researchers found that those who reported eating the most chocolate were more likely toView full resource at blog.nutritiondata.com

  • View Related
  • Share

Most Recently Shared on April 28, 2010 at 3:04 pm By:

23rd Congress Of The European College Of Neuropsychopharmacology (ECNP), Pioneering CNS Research, Translating Neuroscience Into Clinical Progress

medicalnewstoday.com — “Mental disorders, such as depression, anxiety disorders, addiction and schizophrenia are the core challenge of most health care systems around the world. In the EU alone, each year 27% of the totaView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on August 27, 2010 at 2:00 pm By:

mnt_mentalhealt MNT Mental Health Health News

23rd Congress Of The European College Of Neuropsychopharmacology (ECNP), Pioneering CNS Research, Translating Neurosci... http://mnt.to/3HWH

1 year ago...

Family Medicine Article | Depression

mdlinx.com — “Vilazodone: In Major Depressive DisorderView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on June 30, 2011 at 2:43 am By:

Neurology Medical News about Depression

mdlinx.com — “Steroids-Dopamine Interactions in the Pathophysiology and Treatment of CNS DisordersView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on May 26, 2010 at 9:14 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Steroids-Dopamine Interactions in the Pathophysiology and Treatment of CNS Disorders: CNS Neuros... http://bit.ly/cBgasN #neurology #mdlinx

2 years ago...

23rd ECNP Congress: Pioneering CNS Research -- Translating Neuroscience Into Clinical Progress - Health News - redOrbit

redorbit.com — “Mental disorders, such as depression, anxiety disorders, addiction and schizophrenia are the core challenge of most health care systems around the world.View full resource at redorbit.com

  • View Related
  • Share

Most Recently Shared on August 26, 2010 at 11:19 pm By:

Sexual_HealthOW Sexual_HealthOW OW Health

23rd ECNP Congress: Pioneering CNS Research -- Translating Neuroscience Into Clinical Progress: Aug. 28-Sept. 1, 2... http://bit.ly/atS419

1 year ago...

Psychiatry Medical News about Depression

mdlinx.com — “Deficits in Psychological Well-Being and Quality-of-Life in Minor Depression: Implications for DSM-VView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on July 5, 2010 at 2:30 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Deficits in Psychological Well-Being and Quality-of-Life in Minor Depression: Implications for DSM-V: CNS Neur... http://bit.ly/d9Lyss #PSY

2 years ago...

Psychiatry Medical News about Depressive Disorder, Major

mdlinx.com — “Agomelatine in the Treatment of Major Depressive Disorder: Potential for Clinical EffectivenessView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on May 12, 2010 at 1:22 pm By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Agomelatine in the Treatment of Major Depressive Disorder: Potential for Clinical Effectiveness: CNS Drugs http://bit.ly/cf6Kr8 #PSY

2 years ago...

Rexahn Pharmaceuticals Submits Serdaxin Phase IIb Protocol To FDA For Major Depressive Disorder (MDD)

medicalnewstoday.com — “Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing and commercializing potential best in class oncology and CNS therapeutics, announced that it has sView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on September 9, 2010 at 2:00 pm By:

mnt_depression MNT Depression News Health News

Rexahn Pharmaceuticals Submits Serdaxin Phase IIb Protocol To FDA For Major Depressive Disorder (MDD) http://mnt.to/3JtK #depression

1 year ago...

Rexahn Pharmaceuticals Issues Additional Comments And Clarifications On Its Phase IIa Study Results Of Serdaxin In Major Depressive Disorder (MDD)

medicalnewstoday.com — “Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company developing potential best in class oncology and central nervous system (CNS) therapeutics, today offered addiView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on April 16, 2010 at 7:35 am By:

PeterBrownPsy Peter H Brown Doctor and Psychologist

Rexahn Pharmaceuticals Issues Additional Comments And Clarifications On Its Phase IIa Study Results Of Se.. http://mnt.to/f/3BjG #depression

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Related WisdomCards

Related Health Centers

Featuring the top 3 experts for this topic

  • MedicalFeed

    MedicalFeed

    Medical news and updates about medical articles and discussion in Google knols and in many medical websites.

    View Profile

  • PattyGrace

    Patricia Grace

    Founder and CEO Aging with Grace, National Senior Care Examiner, Examiner.com Host, Aging with Grace,BlogTalkRadio

    View Profile

  • NeuraNet

    Neuranet News

    Activity and info of relevance to neurodegenerative diseases of the CNS. Feed administrator: Expert Medical Education.

    View Profile

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390